Kiora Pharmaceuticals Inc Share Price

NASDAQ: KPRX

Small Cap

$2.61

-0.03

(-1.14%)

as on September 16, 2025 at 1:29 am IST

$₹

Kiora Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$2.6
Day's Price Range
$2.7
$2.61
0.38%
Downside
3.45%
Upside
52 Week's Low
52 Week's High
$2.25
52-Week Price Range
$4.18
$2.61
13.79%
Downside
60.15%
Upside

Kiora Pharmaceuticals Inc share price movements today

Previous Close: $2.64
Open: $2.65
Volume: 154.4K
Day's Low - High: $2.6 - $2.7
52 Week Low - High: $2.25 - $4.18

Kiora Pharmaceuticals Inc Historical Returns

1 Month Return: -9.9 %
3 Month Return: -12.58 %
1 Year Return: -27.87 %
3 Year Return: -96.74 %
5 Year Return: 0 %

Kiora Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Kiora Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

-2.23

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-9.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

98297600.00%

Kiora Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kiora Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kiora Pharmaceuticals Inc	BUY	$9.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Kiora Pharmaceuticals Inc Stock including INR - Dollar returns

The Kiora Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Kiora Pharmaceuticals Inc investment value today

Current value as on today

₹76,297

Returns

₹23,703

(-23.7%)

Returns from Kiora Pharmaceuticals Inc Stock

₹28,689 (-28.69%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Kiora Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Kiora Pharmaceuticals Inc. Average target price of $11

Kiora Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Kiora Pharmaceuticals Inc.

What analysts predicted

76.27%UPSIDE

Target Price

$11

Current Price

$2.61

Analyzed by

8 Analysts

Target

$11.00

Kiora Pharmaceuticals Inc target price $11, a slight upside of 76.27% compared to current price of $2.61. According to 8 analysts rating.

Kiora Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Kiora Pharmaceuticals Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:5% versus previous 30 day period

Kiora Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	16	0	-	-15	-	-
Gross Profit	0	0	-1	0	15	0	0	-15	0	0
Operating Income	-1	-2	-5	-2	13	-2	-3	-2	-2	-2
EBITDA	-1	-2	-2	-2	13	-2	-2	-2	-2	-2
Interest Expense	0	-	-	0	-	-	-	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-5	-2	13	-2	-3	-2	-2	-2
Income Tax Expense	0	0	3	0	0	0	-	2	0	0
Net Income	-2	-2	-5	-2	13	-2	-3	-4	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	-799.17%	84.08%	-11108.23%	0.00%	26.48%	0.00%	0.00%

Kiora Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	1	2	0	0	-	-	16
Gross Profit	-7	-9	-6	2	0	0	0	-4	16
Operating Income	-13	-14	-10	-7	-6	-14	-12	-12	4
EBITDA	-13	-14	-10	-6	-6	-13	-10	-12	5
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-13	-14	-10	-7	-6	-13	-13	-12	5
Income Tax Expense	0	-1	0	0	0	0	0	0	2
Net Income	-13	-13	-10	-7	-6	-16	-13	-12	3
Net Profit Margin	-1993.76%	-3243.52%	-654.24%	-264.21%	-56901.65%	-135955.88%	0.00%	0.00%	22.44%

Kiora Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-5	-2	13	-2	-3	-4	-2	-2
Operating Cash Flow	-1	-2	-2	13	-3	0	-2	-2	-3
Investing Cash Flow	-	-	0	-	-21	-1	0	2	0
Financing Cash Flow	5	-	0	15	0	-	-	-	0
Change in Cash	4	-2	-2	28	-24	0	-1	0	-2

Kiora Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-13	-13	-10	-7	-8	-16	-13	-12	3
Operating Cash Flow	-8	-6	-10	-8	-7	-10	-10	-9	8
Investing Cash Flow	0	0	0	0	0	0	0	-	-22
Financing Cash Flow	3	10	11	3	4	17	8	5	15
Change in Cash	-4	4	0	-4	-2	6	-1	-3	1

Global Institutional Holdings in Kiora Pharmaceuticals Inc

Funds	Holdings
Rosalind Advisors, Inc.	8.22%
AIGH Capital Management, LLC	7.11%
Nantahala Capital Management, LLC	6.94%
Stonepine Capital Management Llc	6.59%
ADAR1 Capital Management LLC	6.4%

See all

Insights on Kiora Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 213.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 94.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, KPRX stock has moved down by -10.9%

About Kiora Pharmaceuticals Inc

traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid (“cmha-s”), a modified form of the natural polymer hyaluronic acid (“ha”), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel (“obg”), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy (“prk”) surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone

Organisation	Kiora Pharmaceuticals Inc
Headquarters	332 Encinitas Boulevard, Encinitas, CA, United States, 92024
CEO	Dr. Brian M. Strem Ph.D.
E-voting on shares	Click here to vote

Key Management of Kiora Pharmaceuticals Inc

Name	Title
Dr. Brian M. Strem Ph.D.	President, CEO & Director
Ms. Melissa Tosca CPA	Chief Financial Officer
Dr. Eric J. Daniels M.B.A., M.D.	Chief Development Officer
Dr. Stefan Sperl Ph.D.	Executive Vice President of CMC & Operations

FAQs

What is Kiora Pharmaceuticals Inc share price today?

Kiora Pharmaceuticals Inc share price today is $2.61 as on September 16, 2025 at 1:29 am IST at the close of the market. Kiora Pharmaceuticals Inc share today touched a day high of $2.7 and a low of $2.6.

What is the 52 week high and 52 week low for Kiora Pharmaceuticals Inc share?

Kiora Pharmaceuticals Inc share touched a 52 week high of $4.18 on June 3, 2025 and a 52 week low of $2.25 on August 4, 2025. Kiora Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $2.61,which is 37.56% down from its 52 week high and 16.00% up from its 52 week low.

What is Kiora Pharmaceuticals Inc's market capitalisation today?

Kiora Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Kiora Pharmaceuticals Inc Stock (KPRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kiora Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiora Pharmaceuticals Inc Shares that will get you 0.5747 shares as per Kiora Pharmaceuticals Inc share price of $2.61 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kiora Pharmaceuticals Inc Stock (KPRX) from India?

Indian investors can start investing in Kiora Pharmaceuticals Inc (KPRX) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 2:52 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Kiora Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 2:52 pm IST). Based on Kiora Pharmaceuticals Inc share’s latest price of $2.61 as on September 16, 2025 at 1:29 am IST, you will get 3.8314 shares of Kiora Pharmaceuticals Inc. Learn more about fractional shares .